Valuation: Harbin Pharmaceutical Group Co., Ltd.

Market Cap 13.42B 1.98B 1.74B 1.6B 1.48B 2.79B 191B 2.84B 19.17B 7.53B 93.71B 7.45B 7.28B 322B P/E 2026 *
29.6x
P/E 2027 * 25.4x
Enterprise Value 13.42B 1.98B 1.74B 1.6B 1.48B 2.79B 191B 2.84B 19.17B 7.53B 93.71B 7.45B 7.28B 322B EV / Sales 2026 *
0.82x
EV / Sales 2027 * 0.79x
Free-Float
47.74%
Yield 2026 *
-
Yield 2027 * -
1 day+7.89%
1 week+58.16%
Current month+78.26%
1 month+73.62%
3 months+27.82%
6 months+52.29%
Current year+54.49%
1 week 3.45
Extreme 3.45
5.43
1 month 2.84
Extreme 2.84
5.43
Current year 2.84
Extreme 2.84
5.43
1 year 2.84
Extreme 2.84
5.43
3 years 2.41
Extreme 2.41
5.43
5 years 2.41
Extreme 2.41
5.43
10 years 2.38
Extreme 2.38
9.77
Manager TitleAgeSince
Chief Executive Officer 64 2023-12-26
Director of Finance/CFO 54 2004-12-23
Investor Relations Contact 45 2022-04-26
Director TitleAgeSince
Director/Board Member 60 2020-11-30
Director/Board Member 60 2021-01-07
Chairman 56 2023-12-26
Date Insider Type Main position Quantity % Market Cap.
7/1/24 Sell

Director

22,500 0.0009%
7/1/24 Sell 150,000 0.0060%
7/1/24 Sell 27,000 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
+7.89%+58.16%+35.28%+66.04% 1.98B
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average +0.73%+4.85%+28.85%+56.85% 357.7B
Weighted average by Cap. +0.38%+0.05%+37.75%+81.49%

Financials

2026 *2027 *
Net sales 16.4B 2.42B 2.12B 1.96B 1.8B 3.4B 233B 3.47B 23.42B 9.2B 115B 9.1B 8.9B 393B 16.94B 2.5B 2.19B 2.02B 1.86B 3.51B 241B 3.59B 24.19B 9.5B 118B 9.4B 9.19B 406B
Net income 452M 66.8M 58.51M 54M 49.74M 93.8M 6.43B 95.7M 646M 254M 3.16B 251M 245M 10.85B 520M 76.89M 67.35M 62.16M 57.26M 108M 7.4B 110M 743M 292M 3.63B 289M 282M 12.48B
Net Debt - -
Logo Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the research and development, manufacturing, wholesale and retail of pharmaceutical. The Company is mainly engaged in two businesses. The pharmaceutical industry business is mainly engaged in the research, development and manufacturing of chemical raw materials, chemical preparations, biological preparations, traditional Chinese medicine and health care products. The pharmaceutical commercial business is mainly engaged in pharmaceutical commercial wholesale business and pharmaceutical commercial retail business. The Company's products mainly include zinc gluconate oral solution, calcium iron zinc oral solution, compound calcium gluconate oral solution, amoxicillin capsules and Shuanghuanglian oral solution. The Company's products are mainly used in digestive, respiratory, anti-infectious, cardiovascular and cerebrovascular and anti-tumor treatment fields.
Employees
10,039
Date Price Change Volume
26-07-17 CN¥5.330 +7.89% 874,045,590
26-07-16 CN¥4.940 +10.02% 296,786,688
26-07-15 CN¥4.490 +10.05% 111,552,313
26-07-14 CN¥4.080 +9.97% 440,283,507
26-07-13 CN¥3.710 +10.09% 201,366,438
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.330CNY
Average target price
4.310CNY
Spread / Average Target
-19.14%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600664 Stock